The COVID-19 pandemic has had a significant impact – both positive and negative – on MedTech customers as well as the MedTech industry itself. Similar to how almost all industries have had to adapt to new ways of connecting and conducting business, MedTech manufacturers have changed how they interact with their customers, as well as how their strategies can meet new healthcare needs in an accelerated manner.
Join our roundtable to explore with representatives of the MedTech industry, hospital administrations and medical experts, how COVID-19 has impacted interactions between MedTech companies and hospitals in Europe, as well as resulting challenges and opportunities.
Mohammad Alkaysi, Senior Commercial Excellence & Analytics, Medtronic
Prof. Dr. Andreas Baumbach, Professor for Device Innovation, William Harvey Research Institute, Queen Mary University of London
Prof. Dr. Miguel Ángel Calleja Hernández, Chief of Pharmacy Department, Virgen Macarena University Hospital
Lorenzo T. D’Angelo, PhD, MedTech Global Team, CRA’s Life Sciences Practice
Myriam Mirza, PhD, MedTech Global Team, CRA’s Life Sciences Practice
Wednesday 6 October 2021 — 19:30-20:30 CET / 1:30-2:30 pm ET
To register for this event, click here.